Embolic Protection Competition Fueled By Next-Generation Devices
This article was originally published in The Gray Sheet
Executive Summary
Rapid-exchange versions of Possis Medical's AngioJet XMI and XVG catheters will make the thrombectomy device line a more attractive option for cath labs in the U.S. and abroad, the firm predicts
You may also be interested in...
AngioJet Thrombectomy System Aids Cost Saving In DES Procedures – Possis
The advent of drug-eluting stents (DES) is benefiting sales of Possis Medical's AngioJet Rheolytic thrombectomy system, the firm says
AngioJet Thrombectomy System Aids Cost Saving In DES Procedures – Possis
The advent of drug-eluting stents (DES) is benefiting sales of Possis Medical's AngioJet Rheolytic thrombectomy system, the firm says
Kensey Nash Reviewing TriActiv Distal Protection Marketing Options
Completion of the 50-center, 800-patient, randomized U.S. PRIDE trial of the TriActiv distal protection system in coming months will clear the way for a 510(k) submission by year-end, Kensey Nash says